851845-37-9

AZD 6703 is a p38α MAP kinase inhibitor with activity in inflammatory diseases.

[1] The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases DOI:10.1016/j.bmcl.2012.04.116